{{Short description|Patent medicine}}

'''Bismacine''', also known  as Chromacine, is a substance manufactured by [[American Biologics Corporation]] and marketed as a purported [[alternative medicine|alternative treatment]] for [[Lyme disease]]. Bismacine contains high levels of [[bismuth]], and two deaths are recorded following the use of intravenous bismacine to treat Lyme disease.<ref>{{cite journal | author=Quirk M. | title=Alternative health therapy for Lyme disease results in death | journal=Lancet Infect Dis | year=2006 | volume=6 | issue=8 | pages=546 | doi=10.1016/S1473-3099(06)70563-1 }}</ref> In 2006, the [[U.S. Food and Drug Administration]] warned consumers not to use bismacine, noting that it is ineffective and dangerous.<ref name="fda">{{cite web| publisher = [[U.S. Food and Drug Administration]] | date = 2006-06-21 | title = FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine | url =  https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108696.htm | accessdate = 2008-10-16}}</ref>

==References==
{{reflist}}

[[Category:Bismuth]]
[[Category:Patent medicines]]
[[Category:Lyme disease]]

{{Alt-med-stub}}